Jena, Germany 2/27/08—Laboratory automation supplier CyBio AG announced that it has appointed Dr. Holger Wolf as CEO effective March 1. Mr. Wolf was most recently vice president of Sales, Central Europe, for the Danish medical products firm Coloplast. He joins the company’s executive committee, whose other member is Sonja Strauss.
Japanese R&D funding increased last year, but at a modest level, according to the latest data from the Japanese government. According to recent figures, the country’s total R&D spending rose in fiscal 2006 (April 2006–March 2007), continuing an upward trend, led by spending by private companies. In addition, government R&D funding is set to increase […]
Under a comarketing alliance, CambridgeSoft will market Off-Label.com’s content via its Database Gateway. Phase Forward established a subsidiary within the facilities of its Indian partner, Virtusa, in Hyderabad, India, in November 2007. The Swiss Institute of Bioinformatics, the University of Geneva’s Proteome Informatics Group and Microsoft Research launched a two-year collaborative project to use MS […]
Once again this year, the seasonally strong calendar year 2007 fourth quarter did not disappoint, topping off a year of solid growth for some of the analytical instrument industry’s largest companies. Of the 10 analytical and life science instrument businesses discussed on pages 9–11 that presented quarterly results in US dollars, eight posted double-digit revenue […]
Norwalk, CT 2/29/08—Applera has announced its Celera subsidiary, one of the company’s two tracking stocks, along with Applied Biosystems, will pursue a possible spin-off from Applera to become a separately traded public firm (see IBO 8/15/07). Celera provides diagnostic products and services. Holders of the Celera tracking stock would receive Celera shares in a one-for-one […]
Holliston, MA 2/6/08—Harvard Bioscience announced that it has adopted a shareholders rights plan designed to protect the company in the case of a hostile takeover bid. Each stock holder will recive one preferred stock purchase right per share, which will become exercisable in the event of one person’s purchase of, or tender offer for, 20% […]
It was a familiar story in 2007 for the world’s major pharmaceutical companies. Patent expirations, a decline in new product introductions, and regulatory and cost hurdles were the name of the game. Following in the steps of Merck and Pfizer (see IBO 4/15/06, 2/15/07), a number of the large drug companies announced major cost cutting […]
The Chilean Economic Development Agency (CORFO) estimates that $100 million will be spent on R&D in the country during 2008 through InnovaChile, CORFO’s innovation department. If private industry meets government investment, total R&D funding could reach $200 million this year. The majority of funding will go to clusters recommended by the National Council of Innovation […]
Fluxion Biosciences appointed AutoMate Scientific as a distributor of its BioFlux System. Amaxa and Promega will develop applications based on their respective Nucleofector technology and luciferase reporter assay technologies to monitor cell signaling events in cells that are difficult to transfect. Roche Applied Sciences will exclusively market systems for real-time cell analysis based on ACEA […]
For the fourth quarter of 2007, revenues for IBO’s Laboratory Sales Index grew 13.5% to $4,616 million and operating profits improved 23.0% to $833 million, leading operating margins 140 basis points higher to 18.0% of sales. For the year, the Laboratory Instrument Index reported similar revenue growth, climbing 13.5% to $17,030 million. Operating profits grew […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
